CISN - The OMICS Revolution and Beyond - Personalized Medicine - pg 2
| You Are Here: Home > Cancer Research > What We Know About Cancer > OMICS Revolution > Personalized Medicine - pg 2 | ||||||||
Personalized Medicine - page 2A. CLINICAL INFORMATIONTraditional clinical diagnosis and treatment focuses on the individual patient's clinical Information. That is, the signs and symptoms, medical and family history, and data from laboratory and imaging evaluation needed to diagnose and treat illnesses.
B. ‘OMIC’ INFORMATIONOnce the human genome was categorized, a large increase in data was generated and new approaches to treating patients emerged. |
||||||||
| Section Index | |
| ● | What We Know About Cancer |
| How Cancer is Studied | |
| Drug Development | |
| New Treatments | |
| Research Advocacy | |
We will provide a little bit of information about the various scientific fields of study here but to better understand this topic please go to the the beginning of the 'OMICS' section of our website and read in entirety: https://cisncancer.org/research/what_we_know/omics/omics_revolution.html 1) GenomicsBefore we discuss genomics it is important to understand how it fits into the larger scientific field of biology, so lets start with a few definitions.
This includes the study of gene mutations, both inherited and somatic (mutations that occur in your lifetime). It is these mutations that contribute to the development and spread of cancer.
Genomics plays a part in nine of the ten leading causes of death in the United States (only accidents have no genomic role). "All human beings are 99.9 percent identical in genetic makeup, but differences in the remaining 0.1 percent hold important clues about the causes of disease." Quote from the National Human Genome Research Institute. It is hoped that the study of genomics will help us learn why some people get sick while others do not. A better understanding of the interactions between genes and the environment will help us find better ways to improve health and prevent diseases.
Currently, work in genomics is leading to a better understanding of cancer. Eventually, it could result in tests that predict risk of cancer, diagnose cancer or its recurrence, or used to improve and manage treatment.
One of the greatest impacts of having sequenced the human genome may well be in enabling an entirely new approach to biological research. In the past, researchers studied one or a few genes at a time. With whole-genome sequences and new high-throughput technologies, they can approach questions systematically and on a large scale. They can study all the genes in a genome, for example, or how tens of thousands of genes and proteins work together in interconnected networks to orchestrate the chemistry of life. |
|||||||||||||||||||||||||||||||||



